FDA Drug Application (018279) for K-TAB by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number018279
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage10MEQ
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code BC Extended-release dosage forms (capsules, injectables and tablets)
Reference Drug
Drug NameK-TAB
Active IngredientPOTASSIUM CHLORIDE

Active IngredientCount
List of drugs with Active Ingredient POTASSIUM CHLORIDE279


Back to FDA Applications sponsored by ABBVIE